We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-0.86%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.19B
AUM Growth
-$288M
Cap. Flow
-$155M
Cap. Flow %
-13.04%
Top 10 Hldgs %
42.35%
Holding
170
New
36
Increased
27
Reduced
26
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$49M
2
LLY icon
Eli Lilly
LLY
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$26.3M
4
PANW icon
Palo Alto Networks
PANW
+$13.1M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$60.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.4M
3
GNRC icon
Generac Holdings
GNRC
+$14.3M
4
LPSN icon
LivePerson
LPSN
+$14.2M
5
AMZN icon
Amazon
AMZN
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 63.14%
2 Technology 10.82%
3 Industrials 3.99%
4 Financials 3.13%
5 Communication Services 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.02T
$80.5M 6.76%
348,495
+166,600
+92% +$41.1M
AZN icon
2
AstraZeneca
AZN
$263B
$77.6M 6.52%
645,834
+71,997
+13% +$8.38M
ABBV icon
3
AbbVie
ABBV
$443B
$64.3M 5.4%
596,294
+230,100
+63% +$26.3M
XBI icon
4
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$50.3M 4.22%
400,000
-225,000
-36% -$29M
PFE icon
5
Pfizer
PFE
$143B
$47.6M 4%
+1,106,528
New +$49M
IWM icon
6
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$45.9M 3.86%
210,000
+105,000
+100% +$23.3M
SNY icon
7
Sanofi
SNY
$103B
$40.7M 3.42%
843,400
– –
JNJ icon
8
Johnson & Johnson
JNJ
$618B
$38.6M 3.24%
238,948
-166,660
-41% -$28.4M
BMY icon
9
CALL
Bristol-Myers Squibb
BMY
$133B
$29.6M 2.49%
+500,000
New +$32.9M
GNRC icon
10
Generac Holdings
GNRC
$11.6B
$29M 2.44%
71,013
-33,350
-32% -$14.3M
KYMR icon
11
Kymera Therapeutics
KYMR
$8.51B
$21.1M 1.77%
359,260
+99,365
+38% +$5.76M
MSFT icon
12
Microsoft
MSFT
$3.45T
$19M 1.6%
67,536
– –
CCCC icon
13
C4 Therapeutics
CCCC
$385M
$17.1M 1.43%
381,774
-136,837
-26% -$5.86M
SWTX
14
DELISTED
SpringWorks Therapeutics
SWTX
$15.7M 1.32%
247,917
+52,800
+27% +$4.07M
ZLAB icon
15
Zai Lab
ZLAB
$2.06B
$15.4M 1.29%
145,982
+48,036
+49% +$6.9M
PANW icon
16
Palo Alto Networks
PANW
$270B
$14.8M 1.25%
+186,000
New +$13.1M
KURA icon
17
Kura Oncology
KURA
$800M
$14.8M 1.24%
788,735
-80,151
-9% -$1.51M
SNDX icon
18
Syndax Pharmaceuticals
SNDX
$1.69B
$14.3M 1.21%
750,603
+203,416
+37% +$3.39M
BIIB icon
19
CALL
Biogen
BIIB
$30B
$14.1M 1.19%
50,000
– –
SEDG icon
20
SolarEdge
SEDG
$2.51B
$13.3M 1.11%
50,000
+17,800
+55% +$4.85M
FATE icon
21
Fate Therapeutics
FATE
$286M
$13M 1.09%
219,299
+54,000
+33% +$4.24M
ALT icon
22
Altimmune
ALT
$552M
$12.3M 1.03%
1,088,854
+405,459
+59% +$4.93M
IOVA icon
23
Iovance Biotherapeutics
IOVA
$1.82B
$12.2M 1.03%
494,809
+116,167
+31% +$2.74M
HOWL icon
24
Werewolf Therapeutics
HOWL
$17.2M
$11.8M 0.99%
688,475
-17,819
-3% -$304K
IONS icon
25
CALL
Ionis Pharmaceuticals
IONS
$8.6B
$11.7M 0.99%
350,000
+163,400
+88% +$6.16M
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sphera Funds Management held 170 positions worth $1.19B, down 19% from $1.48B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management withdrew a net $155M in Q3 2021, closing 54 positions and reducing 26 holdings. Its most notable exit was Merck, an estimated $60.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 55% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Pfizer worth $47.6M.

  • Sphera Funds Management's largest Q3 2021 buy was Pfizer: 1,106,528 shares worth $47.6M.
  • Sphera Funds Management added most to Eli Lilly in Q3 2021, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $28.4M.
  • Sphera Funds Management fully exited Merck in Q3 2021, selling an estimated $60.1M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $1.19B portfolio in Q3 2021.
  • Sphera Funds Management opened 36 new positions and closed 54 in Q3 2021.
  • Sphera Funds Management's portfolio value fell 19% quarter-over-quarter to $1.19B.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.